Alzheimer disease (AD) and all other dementing illnesses are, as we never tire of telling medical and graduate students, postdoctoral fellows, and basic neuroscience colleagues, distinctly human ailments. The characteristic patterns of disintegration of the personality that characterize each of them can only be modeled in the human organism. Elegant transgenic animal models may replicate some neuropathologic features of AD, tauopathies, and many other disorders, but correlation of the pathologic brain alterations with neurobehavioral phenomena in affected animals that (with all due respect) have a fairly limited neurobehavioral repertoire becomes problematic.1- 3 Yet without doubt these important transgenic models represent a powerful approach to discovering key therapeutic targets for treating or preventing AD and related dementias—or at least manipulating genes, transcripts, and proteins within the central nervous system that we believe are of pivotal importance in AD pathogenesis.4,5 However, the decades-old exercise of clinicopathologic correlation—establishing the putative morphologic substrate(s) of a given set of signs and symptoms in a patient while she or he was alive—continues to provide extremely valuable data when both the “phenotype” of a disease and its neuropathologic correlates are carefully examined, as they have been in the elegantly simple study reported in this issue by Petersen et al.6
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Thank you for submitting a comment on this article. It will be reviewed by JAMA Neurology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.